HK1178900A1 - Nitrogen containing heteroaryl compounds - Google Patents
Nitrogen containing heteroaryl compoundsInfo
- Publication number
- HK1178900A1 HK1178900A1 HK13105859.4A HK13105859A HK1178900A1 HK 1178900 A1 HK1178900 A1 HK 1178900A1 HK 13105859 A HK13105859 A HK 13105859A HK 1178900 A1 HK1178900 A1 HK 1178900A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- nitrogen containing
- containing heteroaryl
- heteroaryl compounds
- compounds
- nitrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10165427 | 2010-06-09 | ||
PCT/EP2011/059234 WO2011154327A1 (en) | 2010-06-09 | 2011-06-06 | Nitrogen containing heteroaryl compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1178900A1 true HK1178900A1 (en) | 2013-09-19 |
Family
ID=44483879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13105859.4A HK1178900A1 (en) | 2010-06-09 | 2013-05-17 | Nitrogen containing heteroaryl compounds |
Country Status (24)
Country | Link |
---|---|
US (1) | US8703768B2 (xx) |
EP (1) | EP2580207B1 (xx) |
JP (1) | JP5940523B2 (xx) |
KR (1) | KR101757959B1 (xx) |
CN (1) | CN102947292B (xx) |
AR (1) | AR081649A1 (xx) |
BR (1) | BR112012031343A2 (xx) |
CA (1) | CA2799022A1 (xx) |
CL (1) | CL2012003421A1 (xx) |
CO (1) | CO6620065A2 (xx) |
CR (1) | CR20120594A (xx) |
EA (1) | EA022075B1 (xx) |
EC (1) | ECSP12012330A (xx) |
HK (1) | HK1178900A1 (xx) |
IL (1) | IL223069A0 (xx) |
MA (1) | MA34340B1 (xx) |
MX (1) | MX2012013907A (xx) |
NZ (1) | NZ603230A (xx) |
PE (1) | PE20130279A1 (xx) |
SG (1) | SG185655A1 (xx) |
TW (1) | TW201202221A (xx) |
UA (1) | UA108105C2 (xx) |
WO (1) | WO2011154327A1 (xx) |
ZA (1) | ZA201209119B (xx) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2334643A1 (en) * | 2008-10-14 | 2011-06-22 | Actelion Pharmaceuticals Ltd. | Phenethylamide derivatives and their heterocyclic analogues |
SG184475A1 (en) | 2010-04-07 | 2012-11-29 | Hoffmann La Roche | Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
CN103476757A (zh) | 2011-02-18 | 2013-12-25 | 阿勒根公司 | 作为磷酸二酯酶10(pde10a)的抑制剂的取代的6,7-二烷氧基-3-异喹啉醇衍生物 |
SG2014012579A (en) | 2011-09-27 | 2014-04-28 | Hoffmann La Roche | Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
EP2712862A1 (en) * | 2012-09-28 | 2014-04-02 | Splicos | New anti-invasive compounds |
US9586948B2 (en) | 2012-10-08 | 2017-03-07 | Merck Sharp & Dohme Corp. | Inhibitors of IRAK4 activity |
WO2014071044A1 (en) | 2012-11-01 | 2014-05-08 | Allergan, Inc. | Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a) |
CN105189493B (zh) | 2013-02-27 | 2017-04-12 | 持田制药株式会社 | 新型吡唑衍生物 |
KR20160003173A (ko) * | 2013-04-29 | 2016-01-08 | 에프. 호프만-라 로슈 아게 | 2-페닐 또는 2-헤트아릴 이미다졸[1,2-a]피리딘 유도체 |
GB201316600D0 (en) * | 2013-09-18 | 2013-10-30 | Redx Pharma Ltd | Agricultural chemicals |
EP3061754A4 (en) * | 2013-10-23 | 2017-03-22 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
US9200016B2 (en) | 2013-12-05 | 2015-12-01 | Allergan, Inc. | Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) |
KR20170107536A (ko) | 2015-01-30 | 2017-09-25 | 바스프 에스이 | 제초 페닐피리미딘 |
EP3253763B1 (en) * | 2015-02-06 | 2020-09-30 | Merck Patent GmbH | Pyridazinone macrocycles as irak inhibitors and uses thereof |
CN104610189A (zh) * | 2015-02-10 | 2015-05-13 | 佛山市赛维斯医药科技有限公司 | 一类含环丙基脒结构sglt2/sglt1双靶点抑制剂及用途 |
CN104974075A (zh) * | 2015-08-07 | 2015-10-14 | 新秀化学(烟台)有限公司 | 一种n, n-二(2,2,6,6-四甲基-4-哌啶基) -1,3-苯二甲酰胺的制备方法 |
IL264186B1 (en) * | 2016-07-12 | 2024-04-01 | Revolution Medicines Inc | 2,5-dimutomers of 3-methylpyrazines and 2,5,6-dimutomers of 3-methylpyrazines as allosteric SHP2 inhibitors |
CN109476647A (zh) | 2016-07-26 | 2019-03-15 | 巴斯夫欧洲公司 | 除草的嘧啶化合物 |
WO2018019767A1 (en) | 2016-07-27 | 2018-02-01 | Basf Se | Herbicidal pyridine compounds |
CN109475127A (zh) | 2016-07-27 | 2019-03-15 | 巴斯夫欧洲公司 | 除草的嘧啶化合物 |
US20210345613A1 (en) | 2016-07-28 | 2021-11-11 | Basf Se | Herbicidal pyrimidine compounds |
CN110431134A (zh) | 2017-01-23 | 2019-11-08 | 锐新医药公司 | 作为变构shp2抑制剂的吡啶化合物 |
IL296456A (en) | 2017-01-23 | 2022-11-01 | Revolution Medicines Inc | Bicyclics as allosteric shp2 inhibitors |
BR112020007058A2 (pt) | 2017-10-12 | 2020-10-06 | Revolution Medicines, Inc. | compostos de piridina, pirazina, e triazina como inibidores de shp2 alostéricos |
BR112020009757A2 (pt) | 2017-12-15 | 2020-11-03 | Revolution Medicines, Inc. | compostos policíclicos como inibidores alostéricos de shp2 |
WO2019121374A1 (en) | 2017-12-20 | 2019-06-27 | Basf Se | Herbicidal pyrimidine compounds |
WO2019121352A1 (en) | 2017-12-20 | 2019-06-27 | Basf Se | Herbicidal pyrimidine compounds |
JP7403454B2 (ja) * | 2017-12-20 | 2023-12-22 | ピーアイ インダストリーズ リミテッド | ピラゾロピリジン-ジアミド、殺虫剤としてのそれらの使用およびそれらの製造方法 |
CN112955443A (zh) | 2018-09-19 | 2021-06-11 | 拜耳公司 | 具有除草活性的取代的苯基嘧啶酰肼 |
BR112021008524A8 (pt) * | 2018-11-02 | 2023-02-07 | Merck Sharp & Dohme | 2-amino-n-heteroaril-nicotinamidas como inibidores de nav 1.8 |
WO2021085582A1 (ja) | 2019-10-31 | 2021-05-06 | 富士フイルム株式会社 | ピラジン誘導体またはその塩およびその利用 |
JPWO2022025174A1 (xx) | 2020-07-30 | 2022-02-03 | ||
JP2023549494A (ja) | 2020-11-13 | 2023-11-27 | イニファーム,インク. | ジクロロフェノールhsd17b13阻害剤およびその使用 |
EP4319872A1 (en) * | 2021-04-05 | 2024-02-14 | Inipharm, Inc. | Thiazole/isothiazole hsd17b13 inhibitors and uses thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9910079D0 (en) | 1999-05-01 | 1999-06-30 | Smithkline Beecham Plc | Novel compounds |
EP1193261A1 (en) | 2000-10-02 | 2002-04-03 | Warner-Lambert Company | New thiadiazoles and their use as phosphodiesterase-7 inhibitors |
EP1651251A4 (en) | 2003-07-31 | 2008-06-18 | Bayer Pharmaceuticals Corp | METHOD FOR THE TREATMENT OF DIABETES AND RELATED DISEASES USING PDE 10A INHIBITORS |
US7163937B2 (en) | 2003-08-21 | 2007-01-16 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
AU2005215379A1 (en) | 2004-02-12 | 2005-09-01 | Merck & Co., Inc. | Bipyridyl amides as modulators of metabotropic glutamate receptor-5 |
US20060199828A1 (en) | 2005-03-04 | 2006-09-07 | Georg Jaeschke | Pyrazine-2-carboxyamide derivatives |
US7414060B2 (en) | 2005-03-04 | 2008-08-19 | Hoffmann-La Roche Inc. | Pyridine-2-carboxyamide derivatives |
TW200804338A (en) | 2005-11-24 | 2008-01-16 | Astrazeneca Ab | New compounds |
JP5330274B2 (ja) | 2007-03-01 | 2013-10-30 | ノバルティス アーゲー | Pimキナーゼ阻害剤およびその使用方法 |
US20090105124A1 (en) | 2007-08-23 | 2009-04-23 | Kalypsys, Inc. | Heterocyclic modulators of tgr5 |
US8470820B2 (en) | 2010-01-22 | 2013-06-25 | Hoffman-La Roche Inc. | Nitrogen-containing heteroaryl derivatives |
-
2011
- 2011-06-02 US US13/151,301 patent/US8703768B2/en active Active
- 2011-06-06 WO PCT/EP2011/059234 patent/WO2011154327A1/en active Application Filing
- 2011-06-06 EA EA201291282A patent/EA022075B1/ru not_active IP Right Cessation
- 2011-06-06 MA MA35502A patent/MA34340B1/fr unknown
- 2011-06-06 CA CA2799022A patent/CA2799022A1/en not_active Abandoned
- 2011-06-06 SG SG2012085015A patent/SG185655A1/en unknown
- 2011-06-06 CN CN201180027950.8A patent/CN102947292B/zh not_active Expired - Fee Related
- 2011-06-06 EP EP11723077.1A patent/EP2580207B1/en not_active Not-in-force
- 2011-06-06 PE PE2012002298A patent/PE20130279A1/es not_active Application Discontinuation
- 2011-06-06 MX MX2012013907A patent/MX2012013907A/es active IP Right Grant
- 2011-06-06 NZ NZ603230A patent/NZ603230A/xx not_active IP Right Cessation
- 2011-06-06 UA UAA201214955A patent/UA108105C2/ru unknown
- 2011-06-06 JP JP2013513638A patent/JP5940523B2/ja not_active Expired - Fee Related
- 2011-06-06 BR BR112012031343A patent/BR112012031343A2/pt not_active Application Discontinuation
- 2011-06-06 KR KR1020137000568A patent/KR101757959B1/ko active IP Right Grant
- 2011-06-07 AR ARP110101963A patent/AR081649A1/es unknown
- 2011-06-08 TW TW100120008A patent/TW201202221A/zh unknown
-
2012
- 2012-10-26 CO CO12192367A patent/CO6620065A2/es active IP Right Grant
- 2012-11-15 IL IL223069A patent/IL223069A0/en unknown
- 2012-11-26 CR CR20120594A patent/CR20120594A/es unknown
- 2012-12-03 ZA ZA2012/09119A patent/ZA201209119B/en unknown
- 2012-12-05 CL CL2012003421A patent/CL2012003421A1/es unknown
- 2012-12-07 EC ECSP12012330 patent/ECSP12012330A/es unknown
-
2013
- 2013-05-17 HK HK13105859.4A patent/HK1178900A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN102947292B (zh) | 2015-08-19 |
UA108105C2 (xx) | 2015-03-25 |
NZ603230A (en) | 2013-09-27 |
EP2580207B1 (en) | 2017-09-27 |
CO6620065A2 (es) | 2013-02-15 |
ECSP12012330A (es) | 2012-12-28 |
KR101757959B1 (ko) | 2017-07-14 |
EA022075B1 (ru) | 2015-10-30 |
MA34340B1 (fr) | 2013-06-01 |
US20110306589A1 (en) | 2011-12-15 |
WO2011154327A1 (en) | 2011-12-15 |
AR081649A1 (es) | 2012-10-10 |
US8703768B2 (en) | 2014-04-22 |
BR112012031343A2 (pt) | 2016-11-01 |
MX2012013907A (es) | 2012-12-17 |
IL223069A0 (en) | 2013-02-03 |
EP2580207A1 (en) | 2013-04-17 |
CN102947292A (zh) | 2013-02-27 |
TW201202221A (en) | 2012-01-16 |
KR20130112858A (ko) | 2013-10-14 |
PE20130279A1 (es) | 2013-03-08 |
CA2799022A1 (en) | 2011-12-15 |
JP5940523B2 (ja) | 2016-06-29 |
SG185655A1 (en) | 2012-12-28 |
CR20120594A (es) | 2013-01-03 |
ZA201209119B (en) | 2015-05-27 |
CL2012003421A1 (es) | 2013-07-26 |
EA201291282A1 (ru) | 2013-06-28 |
JP2013528193A (ja) | 2013-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1178900A1 (en) | Nitrogen containing heteroaryl compounds | |
EP2635285A4 (en) | HETEROARYL COMPOUNDS AND USES THEREOF | |
GB201005589D0 (en) | Novel compounds | |
EP2563122A4 (en) | CHEMICAL COMPOUNDS | |
EP2549868A4 (en) | CHEMICAL COMPOUNDS | |
HK1171744A1 (en) | Nitrogen-containing heteroaryl derivatives | |
EP2635279A4 (en) | CHEMICAL COMPOUNDS | |
GB201016855D0 (en) | Chemical compounds | |
GB201008290D0 (en) | Chemical compounds | |
GB201012686D0 (en) | Novel compounds | |
GB201007791D0 (en) | Novel compounds | |
GB201021310D0 (en) | Novel compounds | |
GB201021314D0 (en) | Novel compounds | |
GB201021311D0 (en) | Novel compounds | |
GB201020909D0 (en) | Novel compounds | |
GB201020607D0 (en) | Novel compounds | |
GB201019576D0 (en) | Novel compounds | |
GB201019547D0 (en) | Novel compounds | |
GB201019575D0 (en) | Novel compounds | |
GB201019480D0 (en) | Novel compounds | |
GB201014230D0 (en) | Novel compounds | |
GB201014232D0 (en) | Novel compounds | |
GB201014231D0 (en) | Novel compounds | |
GB201012922D0 (en) | Novel compounds | |
GB201010512D0 (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190601 |